Propofol potentiates phenylephrine-induced contraction via cyclooxygenase inhibition in pulmonary artery smooth muscle

Anesthesiology

Volumn 94, Issue 5, 2001, Pages 833-839

  Ogawa, Koji ^a   Tanaka, Satoru ^a   Murray, Paul A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANESTHETIC AGENT; ARACHIDONIC ACID; CALCIUM; IBUPROFEN; PHENYLEPHRINE; PROPOFOL; PROSTACYCLIN; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL TISSUE; ARTERY MUSCLE; ARTERY TONE; ARTICLE; CONCENTRATION RESPONSE; DOG; DRUG EFFECT; DRUG POTENTIATION; ENDOTHELIUM; ENZYME IMMUNOASSAY; ENZYME INHIBITION; LUNG ARTERY; LUNG VASOCONSTRICTION; MALE; NONHUMAN; PRIORITY JOURNAL; VASODILATATION;

EID: 0035025037     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200105000-00022     Document Type: Article

References (29)

1. Nakamura K, Hatano Y, Hirakata H, Nishiwada M, Toda H, Mori K: Direct vasoconstrictor and vasodilator effects of propofol in isolated dog arteries. Br J Anaesth 1992; 68:193-7
2. Yamanoue T, Brum JM, Estafanous FG: Vasodilation and mechanism of action of propofol in porcine coronary artery. ANESTHESIOLOGY 1994; 81:443-51
3. Gelb AW, Zhang C, Hamilton JT: Propofol induces dilation and inhibits constriction in guinea pig basilar arteries. Anesth Analg 1996; 83:472-6
4. Kamitani K, Yamazaki M, Yukitaka M, Ito Y, Momose Y: Effects of propofol on isolated rabbit mesenteric arteries and veins. Br J Anaesth 1995; 75:457-61
5. 2+ channel blocker. Anesth Analg 1993; 76:24-32
6. Kondo U, Nakayama M, Murray PA: Effects of propofol anesthesia on pulmonary vascular response to sympathetic α and β adrenoreceptor activation in chronically-instrumented dogs (abstract). ANESTHESIOLOGY 1998; 89:A1369
7. Baudouin SV, Messent M, Evans TW: Effect of Intralipid on hypoxic and angiotension-II induced pulmonary vasoconstriction in the isolated rat lung. Crit Care Med 1994; 22:1964-8
8. Horibe M, Ogawa K, Sohn J, Murray PA: Propofol attenuates acetylcholine-induced pulmonary vasorelaxation in dogs: Role of NO and EDHF. ANESTHESIOLOGY 2000; 93:447-55
9. Gu H, Martin H, Barsotti RJ, Labelle EF: Rapid increase in inositol phosphate levels in norepinephrine-stimulated vascular smooth muscle. Am J Physiol 1999; 261:C17-22
10. 2 in norepinephrine-induced arachidonic acid release in rabbit aortic smooth muscle cells. J Biol Chem 1996; 271:30149-57
11. Nishizuka Y: Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992; 258:607-14
12. Karaki H, Ozaki H, Hori M, Mitsui-Saito M, Amano K, Harada K, Miyamoto S, Nakazawa H, Won KJ, Sato K: Calcium movements, distribution, and function in smooth muscle. Pharmacol Rev 1997; 49:157-230
13. Migas I, Severson DL: Diacylglycerols derived from membrane phospholipids are metabolized by lipase in A10 smooth muscle cells. Am J Physiol 1996; 271:C1194-202
14. ++ channel through a pertussis toxin-sensitive guanine nucleotide-binding protein. J Pharmacol Exp Ther 1993; 266: 1113-24
15. 2. Am J Physiol 1998; 274: C1129-37
16. Smith WL: The eicosanoids and their biochemical mechanisms of action. Biochem J 1989; 259:315-24
17. Hadhazy P, Magyar K: Feedback control of arterial smooth muscle tone: The role of prostacyclin. Br J Pharmacol 1986; 89:861-3
18. Wang HL, Voelkel NF: Norepinephrine induces lung vascular prostacyclin synthesis via α1-adrenergic receptors. J Appl Physiol 1989; 67:330-8
19. 2+ levels and muscle contraction in isolated guinea pig aotra. Jpn J Pharmacol 1996; 71:231-7
20. Kelicen P, Ismailoglu UB, Erdemli O, Sahin-Erdemli I: The effect of propofol and thiopentone on impariment by reactive oxygen species of endothelium-dependent relaxation in rat aortic rings. Eur J Anaesth 1997; 14:310-5
21. Bao YP, Williamson G, Tew D, Plumb GW, Lambert N, Jones JG, Menon DK: Antioxidant effects of propofol in human hepatic microsomes: Concentration effects and clinical relevance. Br J Anaesth 1998; 81:584-9
22. De La Cruz JP, Sedeno G, Carmona JA, Sanchez dela Cuesta F: The in vitro effects of propofol on tissular oxidative stress in the rat. Anesth Analg 1998; 87:1141-6
23. Murphy PG, Myers DS, Davis MJ, Webster NR, Jones JG: The antioxidant potential of propofol (2,6-diisopropylphenol). Br J Anaesth 1992; 68:613-8
24. Green TR, Bennet SR, Nelson VM: Specificity and properties of propofol as an antioxidant free radical scavenger. Toxicol Appl Pharmacol 1994; 129:163-9
25. Zusman RM: Eicosanoids: Prostaglandins, thromoxane, and prostacyclin, The Heart and Cardiovascular System. Scientific Foundations. Edited by Fozzard HA, Haber E, Jennings RB. New York, Raven Press, 1991, pp 1797-815
26. Agradi E, Petroni A, Socini A, Galli C: In vitro effects of synthetic antioxidants and vitamin E on arachidonic acid metabolism and thromboxane formation in human platelets and on platelet aggregation. Prostaglandins 1981; 22:255-66
27. Panganamala RV, Miller JS, Gwebu ET, Sharma HM, Cornwell DG: Differential inhibitory effects of vitamin E and other antioxidants on prostaglandin synthase, platelet aggregation and lipoxidase. Prostaglandins Leukot Med 1977; 14:261-71
28. 50 of propofol for loss of consciousness and skin incision. ANESTHESIOLOGY 1994; 81:820-8
29. Servin F, Desmonts JM, Haberer JP, Cockshott ID, Plummer GF, Farinotti R: Pharmacokinetics and protein binding of propofol in patients with cirrhosis. ANESTHESIOLOGY 1988; 69:887-91